Tue, November 16, 2010
Mon, November 15, 2010
Sun, November 14, 2010
Fri, November 12, 2010
Thu, November 11, 2010
Wed, November 10, 2010
Tue, November 9, 2010
Mon, November 8, 2010
Sun, November 7, 2010
Sat, November 6, 2010
Fri, November 5, 2010
Thu, November 4, 2010
Wed, November 3, 2010
Tue, November 2, 2010
Mon, November 1, 2010
Sat, October 30, 2010
Fri, October 29, 2010
Thu, October 28, 2010

Berman DeValerio Announces Investigation Into MannKind Corp.


//health-fitness.news-articles.net/content/2010/ .. -announces-investigation-into-mannkind-corp.html
Published in Health and Fitness on Friday, November 5th 2010 at 11:26 GMT by Market Wire   Print publication without navigation


BOSTON--([ BUSINESS WIRE ])--The law firm of Berman DeValerio is investigating possible violations of securities law and/or breaches of fiduciary duty by MannKind Corp. (Nasdaq: MNKD) ("MannKind" or the "Company") and its officers and directors.

The investigation was initiated today on news that MannKind's former senior director for regulatory affairs filed a lawsuit accusing the Company of covering up potential fraud in clinical trials for a new diabetes treatment. In his September lawsuit, the former employee, John Arditi, claims that he was fired by the Company after discovering possible fraud in studies for the drug, Afrezza. The U.S. Food and Drug Administration was set to rule on the biotech companys diabetes treatment by December 29.

If you have information regarding these allegations or are a MannKind shareholder who would like to learn about your legal options, you may contact the following attorneys at Berman DeValerio for more information.

This notice may constitute attorney advertising.


Publication Contributing Sources